Baldini N - Search Results

1

Clinical Trial of Radiotherapy After Intravenous Injection of Acridine Orange for Patients with Cancer.

Kusuzaki K, Takai T, Yoshimura H, Inoue K, Takai S, Baldini N. Kusuzaki K, et al. Among authors: baldini n. Anticancer Res. 2018 Jan;38(1):481-489. doi: 10.21873/anticanres.12248. Anticancer Res. 2018. PMID: 29277813

2

Photodynamic Surgery for Feline Injection-Site Sarcoma.

Martano M, Morello E, Avnet S, Costa F, Sammartano F, Kusuzaki K, Baldini N. Martano M, et al. Among authors: baldini n. Biomed Res Int. 2019 Jul 8;2019:8275935. doi: 10.1155/2019/8275935. eCollection 2019. Biomed Res Int. 2019. PMID: 31360726 Free PMC article.

3

Acridine Orange is an Effective Anti-Cancer Drug that Affects Mitochondrial Function in Osteosarcoma Cells.

Fotia C, Avnet S, Kusuzaki K, Roncuzzi L, Baldini N. Fotia C, et al. Among authors: baldini n. Curr Pharm Des. 2015;21(28):4088-94. doi: 10.2174/1381612821666150918144953. Curr Pharm Des. 2015. PMID: 26381269

4

Radiodynamic Therapy with Acridine Orange Is an Effective Treatment for Bone Metastases.

Di Pompo G, Kusuzaki K, Ponzetti M, Leone VF, Baldini N, Avnet S. Di Pompo G, et al. Among authors: baldini n. Biomedicines. 2022 Aug 5;10(8):1904. doi: 10.3390/biomedicines10081904. Biomedicines. 2022. PMID: 36009451 Free PMC article.

5

Translational research of photodynamic therapy with acridine orange which targets cancer acidity.

Kusuzaki K, Hosogi S, Ashihara E, Matsubara T, Satonaka H, Nakamura T, Matsumine A, Sudo A, Uchida A, Murata H, Baldini N, Fais S, Marunaka Y. Kusuzaki K, et al. Among authors: baldini n. Curr Pharm Des. 2012;18(10):1414-20. doi: 10.2174/138161212799504812. Curr Pharm Des. 2012. PMID: 22360555 Clinical Trial.

6

Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment.

Perut F, Carta F, Bonuccelli G, Grisendi G, Di Pompo G, Avnet S, Sbrana FV, Hosogi S, Dominici M, Kusuzaki K, Supuran CT, Baldini N. Perut F, et al. Among authors: baldini n. Expert Opin Ther Targets. 2015;19(12):1593-605. doi: 10.1517/14728222.2016.1086339. Epub 2015 Sep 10. Expert Opin Ther Targets. 2015. PMID: 26357839

7

Tumour-specific metabolic adaptation to acidosis is coupled to epigenetic stability in osteosarcoma cells.

Chano T, Avnet S, Kusuzaki K, Bonuccelli G, Sonveaux P, Rotili D, Mai A, Baldini N. Chano T, et al. Among authors: baldini n. Am J Cancer Res. 2016 Mar 15;6(4):859-75. eCollection 2016. Am J Cancer Res. 2016. PMID: 27186436 Free PMC article.

8

Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance.

Avnet S, Lemma S, Cortini M, Pellegrini P, Perut F, Zini N, Kusuzaki K, Chano T, Grisendi G, Dominici M, De Milito A, Baldini N. Avnet S, et al. Among authors: baldini n. Oncotarget. 2016 Sep 27;7(39):63408-63423. doi: 10.18632/oncotarget.11503. Oncotarget. 2016. PMID: 27566564 Free PMC article.

9

Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells.

Bonuccelli G, Avnet S, Grisendi G, Salerno M, Granchi D, Dominici M, Kusuzaki K, Baldini N. Bonuccelli G, et al. Among authors: baldini n. Oncotarget. 2014 Sep 15;5(17):7575-88. doi: 10.18632/oncotarget.2243. Oncotarget. 2014. PMID: 25277190 Free PMC article.

10

Adriamycin binding assay: a valuable chemosensitivity test in human osteosarcoma.

Baldini N, Scotlandi K, Serra M, Kusuzaki K, Shikita T, Manara MC, Maurici D, Campanacci M. Baldini N, et al. J Cancer Res Clin Oncol. 1992;119(2):121-6. doi: 10.1007/BF01209668. J Cancer Res Clin Oncol. 1992. PMID: 1358894

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters